KIU News

  • Home /
  • KIU News /
  • KIU International Desk: China Commits to International Cooperation in COVID-19 Vaccine Trials

KIU International Desk: China Commits to International Cooperation in COVID-19 Vaccine Trials

kiu-international-desk-china-commits-to-international-cooperation-in-covid-19-vaccine-trials

KIU, Main Campus - China is expending great efforts in the global scramble to develop a vaccine for the new Coronavirus pandemic that began in its central city of Wuhan. According to the World Health Organization (WHO), researchers are currently conducting five separate clinical trials on humans, or half of all such trials globally.

In May, at the World Health Assembly - the WHO’s governing body, President Xi Jinping vowed that the vaccines China develops will become a “global public good” once they are ready for use, and it will register as China’s contribution to ensuring vaccine accessibility and affordability in developing countries.

China’s Science and Technology Minister, Wang Zhigang, expressed that developing a vaccine was still the fundamental strategy in their effort to overcome the Coronavirus, despite how difficult vaccine development was.

“The rigour of vaccine development has been compared by some scientists to a dance involving precise steps and rehearsals,” Wang said.

Picture credit: xinhuanet.com